Stay updated with breaking news from Recommended Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investegate announcements from https://immatics.com/, Immatics Announces First Quarter 2022 Financial Results and Business Update
A No-Objection Letter from Health Canada has been received, enabling the initiation of PNT2004’s Phase 1 therapeutic trial using 68Ga-PNT6555 for imaging and 177Lu-PNT6555 for therapy ... | May 16, 2022
Oryzon invests $4.2 million in R&D in the first quarter 2022...
/PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today...
05.05.2022 - Oryzon invests $4.2 million in R&D in the first quarter 2022MADRID, Spain and CAMBRIDGE, Mass., May 05, 2022 (GLOBE NEWSWIRE) - Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics ...